Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Account Payables (2018 - 2025)

Viemed Healthcare's Change in Account Payables history spans 8 years, with the latest figure at -$288000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 25.77% year-over-year to -$288000.0; the TTM value through Dec 2025 reached $479000.0, up 33.43%, while the annual FY2025 figure was $479000.0, 33.43% up from the prior year.
  • Change in Account Payables reached -$288000.0 in Q4 2025 per VMD's latest filing, up from -$831000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.3 million in Q3 2021 to a low of -$2.5 million in Q4 2021.
  • Average Change in Account Payables over 5 years is -$10300.0, with a median of $74000.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: skyrocketed 394.74% in 2022, then tumbled 604.02% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$2.5 million in 2021, then skyrocketed by 85.99% to -$351000.0 in 2022, then plummeted by 72.08% to -$604000.0 in 2023, then skyrocketed by 35.76% to -$388000.0 in 2024, then grew by 25.77% to -$288000.0 in 2025.
  • Per Business Quant, the three most recent readings for VMD's Change in Account Payables are -$288000.0 (Q4 2025), -$831000.0 (Q3 2025), and $422000.0 (Q2 2025).